loadpatents
name:-0.17377400398254
name:-0.77745509147644
name:-0.00068402290344238
Melmed; Shlomo Patent Filings

Melmed; Shlomo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Melmed; Shlomo.The latest application filed is for "treatment of pituitary corticotroph tumors using r-roscovitine".

Company Profile
0.18.40
  • Melmed; Shlomo - Los Angeles CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for treatment of Cushing'S disease and hypercortisolism using gefitinib
Grant 9,387,211 - Fukuoka , et al. July 12, 2
2016-07-12
Method for drug screening and characterization by calcium flux
Grant 8,709,804 - Ben-Shlomo , et al. April 29, 2
2014-04-29
Treatment Of Pituitary Corticotroph Tumors Using R-roscovitine
App 20130171073 - Melmed; Shlomo ;   et al.
2013-07-04
Use Of Tyrosine Kinase Inhibitors For Treatment Of Prolactinoma
App 20120308567 - Fukuoka; Hidenori ;   et al.
2012-12-06
Use Of Tyrosine Kinase Inhibitors For Treatment Of Cushing's Disease And Hypercortisolism
App 20120301470 - Fukuoka; Hidenori ;   et al.
2012-11-29
PTTG1 as a biomarker for cancer treatment
Grant 8,216,782 - Tong , et al. July 10, 2
2012-07-10
Pttg1 As A Biomarker For Cancer Treatment
App 20110009473 - Tong; Yunguang ;   et al.
2011-01-13
Method for Drug Screening and Characterization by Calcium Flux
App 20080253641 - Ben-Shlomo; Anat ;   et al.
2008-10-16
Treatment of anoragasmia or delayed orgasm
App 20070155770 - Melmed; Shlomo ;   et al.
2007-07-05
Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor
Grant 7,097,829 - Heaney , et al. August 29, 2
2006-08-29
Transgenic expression from a SOCS-3 promoter in vertebrate cells
Grant 6,943,018 - Auernhammer , et al. September 13, 2
2005-09-13
Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
Grant 6,939,544 - Horwitz , et al. September 6, 2
2005-09-06
Method for treating a condition with a cytokine of the GP130 subunit signaling family linked to a polynucleotide encoding SOCS-3
App 20050188429 - Auernhammer, Christoph J. ;   et al.
2005-08-25
Somatic cells, germ cells and cell lines derived from a PTTG knockout rodent
App 20050177887 - Melmed, Shlomo ;   et al.
2005-08-11
Method for treating a condition with a SOCS-3 promoter linked to a polynucleotide encoding SOCS-3
App 20050172346 - Auernhammer, Christoph J. ;   et al.
2005-08-04
Method of regulating biological activity of pituitary tumor transforming gene (PTTG)1 using PTTG2
Grant 6,913,926 - Prezant , et al. July 5, 2
2005-07-05
Rat PTTG polypeptide and method for producing it
Grant 6,911,320 - Melmed , et al. June 28, 2
2005-06-28
PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
Grant 6,909,030 - Melmed , et al. June 21, 2
2005-06-21
Human PTTG polypeptide and method for producing it
Grant 6,900,032 - Melmed , et al. May 31, 2
2005-05-31
Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
Grant 6,894,031 - Horwitz , et al. May 17, 2
2005-05-17
Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
Grant 6,858,586 - Horwitz , et al. February 22, 2
2005-02-22
Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
Grant 6,835,380 - Horwitz , et al. December 28, 2
2004-12-28
Compositions and method for determining the presence of human PTTG peptide in a sample
Grant 6,750,327 - Melmed , et al. June 15, 2
2004-06-15
Compositions and method for determining the presence of rat PTTG peptide in a sample
Grant 6,723,519 - Melmed , et al. April 20, 2
2004-04-20
Use of peroxisome proliferator activated receptor (PPAR)-.gamma. ligands as a treatment for pituitary tumors and associated conditions, such as Cushing's syndrome
Grant 6,673,823 - Heaney , et al. January 6, 2
2004-01-06
Use Of Peroxisome Proliferator Activated Receptor (ppar)-gamma Ligands As A Treatment For Pituitary Tumors And Associated Conditions, Such As Cushing's Syndrome
App 20030225139 - Heaney, Anthony P. ;   et al.
2003-12-04
Live cell method for observing cellular processes
App 20030190641 - Yu, Run ;   et al.
2003-10-09
Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
App 20030186286 - Auernhammer, Christoph J. ;   et al.
2003-10-02
Polynucleotides encoding rat pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030186910 - Horwitz, Gregory A. ;   et al.
2003-10-02
Method of regulating biological activity of pituitary tumor transforming gene (PTTG)1 using PTTG2
App 20030186902 - Prezant, Toni Rita ;   et al.
2003-10-02
Antibodies against pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
App 20030175266 - Horwitz, Gregory A. ;   et al.
2003-09-18
Transgenic non-human mammals carrying rat pituitary tumor transforming gene (PTTG) sequences
App 20030177511 - Melmed, Shlomo ;   et al.
2003-09-18
Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
App 20030167496 - Melmed, Shlomo ;   et al.
2003-09-04
Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
App 20030152573 - Horwitz, Gregory A. ;   et al.
2003-08-14
Rat pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030153522 - Horwitz, Gregory A. ;   et al.
2003-08-14
Oligonucleotides antisense to rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030148977 - Horwitz, Gregory A. ;   et al.
2003-08-07
Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
App 20030147892 - Horwitz, Gregory A. ;   et al.
2003-08-07
Oligonucleotides antisense to mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030148978 - Horwitz, Gregory A. ;   et al.
2003-08-07
Non-human mammals comprising cells expressing vector-borne rat PTTG carboxy-terminal-related DNA
App 20030140359 - Horwitz, Gregory A. ;   et al.
2003-07-24
Polynucleotides encoding mouse pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030130219 - Horwitz, Gregory A. ;   et al.
2003-07-10
Non-human mammals comprising cells expressing vector-borne mouse PTTG carboxy-terminal-related DNA
App 20030131366 - Horwitz, Gregory A. ;   et al.
2003-07-10
Mouse pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030114378 - Horwitz, Gregory A. ;   et al.
2003-06-19
PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
App 20030106080 - Melmed, Shlomo ;   et al.
2003-06-05
Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and ues therefor
App 20030100530 - Heaney, Anthony P. ;   et al.
2003-05-29
Non-human mammals comprising cells expressing vector-borne PTTG carboxy-terminal-related DNA
App 20030079242 - Horwitz, Gregory A. ;   et al.
2003-04-24
Pituitary-tumor-transforming-genes, and related products
App 20030069197 - Melmed, Shlomo ;   et al.
2003-04-10
Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
App 20030031662 - Horwitz, Gregory A. ;   et al.
2003-02-13
Methods of using pituitary tumor transforming gene (PTTG) carboxy-terminal peptides to inhibit neoplastic cellular proliferation and/or transformation of breast and ovarian cells
App 20030018001 - Heaney, Anthony P. ;   et al.
2003-01-23
Transgenic expression from a SOCS-3 promoter in vertebrate cells
App 20020174448 - Auernhammer, Christoph J. ;   et al.
2002-11-21
Anti-inflammatory therapies using cytokine signaling regulated by a SOCS-3 promoter
App 20020166136 - Auernhammer, Christoph J. ;   et al.
2002-11-07
Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
App 20020147162 - Heaney, Anthony P. ;   et al.
2002-10-10
Human PTTG polypeptide and method for producing it
App 20020106778 - Melmed, Shlomo ;   et al.
2002-08-08
Rat PTTG polypeptide and method for producing it
App 20020086845 - Melmed, Shlomo ;   et al.
2002-07-04
Compositions and method for determining the presence of rat PTTG peptide in a sample
App 20020068716 - Melmed, Shlomo ;   et al.
2002-06-06
Compositions and method for determining the presence of human PTTG peptide in a sample
App 20020068353 - Melmed, Shlomo ;   et al.
2002-06-06
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed